Insulin-like growth factor (IGF)-1 was previously shown to up-regulate MMP-2 production in lung cancer [72], whereas the interleukin (IL)-10/IL-10 receptor axis was found to down-regulate MMP-2 synthesis in prostate cancer cell line PC3 ML [73]. This evidence concerns the gene IL10 and prostate carcinoma.